MEDCAW INVESTMENTS PLC financials
MEDCAW INVESTMENTS PLC
213800UTM4MRTZHJ8C21 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | £0 | £0 |
| Administrative expenses | £118.5K | £267.1K |
| Operating profit (EBIT) | -£118.5K | -£463.2K |
| Net finance income / (cost) | -£26.0K | £30.9K |
| Profit before tax | -£144.5K | -£432.4K |
| Income tax expense | £0 | £0 |
| Profit for the year | -£144.5K | -£432.4K |
| Total comprehensive income | -£144.5K | -£432.4K |
| Cash flow statement | ||
| Net cash from operating activities | -£133.9K | £196.8K |
| Net cash from investing activities | £51.7K | -£165.3K |
| Net cash from financing activities | £0 | £0 |
| Balance sheet | ||
| Total assets | £365.2K | £98.5K |
| Cash & equivalents | £320.8K | £72.3K |
| Total equity | -£256.7K | -£163.3K |
| Trade & other payables | £96.9K | £261.8K |
| Derived metrics | ||
| Return on equity | 56.3% | 264.8% |
| Cash conversion ratio | 0.93× | -0.46× |
| Other reported items | ||
| Adjustments For Decrease Increase In Trade and Other Receivables | £114.1K | -£18.1K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | £196.1K | £0 |
| Adjustments For Increase Decrease In Trade and Other Payables | £19.0K | £359.4K |
| Adjustments For Interest Income | £30.9K | £0 |
| Equity and Liabilities | £256.1K | £163.3K |
| Increase Decrease In Cash and Cash Equivalents | £248.5K | -£299.2K |
| Increase Decrease Through Transactions With Owners | £51.7K | £0 |
| Issue of Equity | — | £0 |
| Issued Capital | £221.3K | £221.3K |
| Liabilities | £621.2K | £261.8K |
| Net Assets Liabilities | -£256.1K | -£163.3K |
| Other Comprehensive Income | £0 | £0 |
| Other Current Assets | £44.3K | £26.2K |
| Other Current Liabilities | £524.3K | £0 |
| Other Inflows Outflows of Cash Classified As Financing Activities | — | £0 |
| Reserve of Equity Component of Convertible Instruments | £51.7K | £0 |
| Reserve of Sharebased Payments | £14.9K | £14.9K |
| Retained Earnings | -£1.5M | -£1.4M |
| Share Premium | £1.0M | £1.0M |
Every line item above is a fact tagged in MEDCAW INVESTMENTS PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.